Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



One Tip to Prime Your Portfolio

One thing that often gets lost in all of the talk of sizzling stocks and 20-baggers is the benefit of diversification. It's a concept every investor can understand and profit from.

And don't think diversification automatically means mediocre returns. David and Tom Gardner have led Motley Fool Stock Advisor members through a variety of industries, and even some international exposure, on the way to outsized performance (57% total average returns versus 17% in the S&P 500). So it can be done.

You, too, can construct a portfolio in a sensible enough way to significantly lower your risk, even if you own very few stocks. Here's how.

Negative is good
Always try to consider how each potential new purchase relates to the rest of your portfolio. If Merck (NYSE: MRK  ) and Pfizer (NYSE: PFE  ) already make up a big chunk of your holdings, it's best to avoid another drug manufacturer when buying more stock. Even if you think it would provide you with great returns, if the industry falls apart (translation: you end up being wrong), you'll be in for a lot of pain. Even if you are eventually right in your analysis, you'll still be in pain if you have to sell unexpectedly and the industry remains depressed for an extended period.

The next logical step, then, is to aim for great stocks with a low or negative correlation. That simply means that although they'll all hopefully rise in value over the long term, you'll want stocks that tend to move in relatively different directions along the way. One zigs, the other zags, and your portfolio's returns will be much smoother as a result. Consider (Nasdaq: NTES  ) and Boeing (NYSE: BA  ) . It makes intuitive sense that the Internet and defense/aerospace industries would not move in lockstep, and a glance at any chart shows this to be true.

The best news is that it's fairly easy to gain this benefit. It doesn't take a detailed scientific analysis. In his classic book A Random Walk Down Wall Street, Princeton professor Burton Malkiel notes that "anything less than perfect positive correlation can potentially reduce risk."

The right way to do it
Here's a good example. In Stock Advisor, Tom refers to his method as "industry rotation." His goal is to find the best companies in beaten-down industries that are ready to rebound. Such stocks are among the market's best performers when the turnaround comes, as it inevitably does in a relevant industry. Think of how ConocoPhillips (NYSE: COP  ) and PetroChina (NYSE: PTR  ) moved ahead as worldwide demand for oil has increased -- each easily topped the market since 2003 despite the industry being in the doldrums from 2000 to 2002.

Let's take a look at two of Tom's stocks from different industries to highlight the diversification benefit. BorgWarner supplies powertrain parts to auto manufacturers. Quality Systems provides medical-records software to doctors and dentists. Both have achieved stellar gains since Tom recommended them in early 2003 (261% and 401%, respectively). But they moved differently enough so that their combined return (especially in the early months) was much smoother than either of them achieved separately.

The Foolish bottom line
I don't use these examples to applaud Tom and David's stock-picking skills. Rather, my aim is to highlight the importance of diversification, even when choosing a relatively small number of stocks. Certainly, not all stocks will be winners. But by spreading picks across sectors, you're giving yourself a chance for sensible diversification and a smoother road to long-term success.

Right now, a 30-day free trial to Stock Advisor will not only get you every recommendation they've ever made, but you'll also be able to follow Tom along the industry carousel. Plus, each newsletter now includes Tom or Dave's top five stocks to buy now. Here's more information.

This article was originally published as "Are You Invested in the Right Industries?" on April 5, 2006. It has been updated.

Rex Moore never met a deadline he didn't meet. At time of publication, he owned no companies mentioned in this article. Pfizer is a Motley Fool Inside Value recommendation. NetEase is a Rule Breakers recommendation. The Motley Fool is investors writing for investors.

Read/Post Comments (0) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 564069, ~/Articles/ArticleHandler.aspx, 10/25/2016 10:20:30 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 1 hour ago Sponsored by:
DOW 18,169.27 -53.76 -0.30%
S&P 500 2,143.16 -8.17 -0.38%
NASD 5,283.40 -26.43 -0.50%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/25/2016 4:00 PM
BA $139.02 Up +1.57 +1.14%
Boeing CAPS Rating: ****
COP $41.81 Down -0.43 -1.02%
ConocoPhillips CAPS Rating: ****
MRK $61.95 Up +1.20 +1.98%
Merck and Co. CAPS Rating: ****
NTES $269.60 Up +2.42 +0.91%
NetEase CAPS Rating: ****
PFE $32.28 Up +0.15 +0.47%
Pfizer CAPS Rating: ****
PTR $71.80 Down -1.42 -1.94%
PetroChina CAPS Rating: ***